Article Details

Sangamo Therapeutics to Regain Full Rights to Hemophilia A Gene Therapy Program ...

Retrieved on: 2024-12-31 21:33:25

Tags for this article:

Click the tags to see associated articles and topics

Sangamo Therapeutics to Regain Full Rights to Hemophilia A Gene Therapy Program .... View article details on hiswai:

Excerpt

Based on positive results from Phase 3 AFFINE trial, which met primary and secondary endpoints, Sangamo plans to explore all options to ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up